Registration open: EURETINA 2021 virtual programme covers 4 days, 5 channels

Article

Programming includes 16 EURETINA sessions; 22 symposia; 44 instructional courses; 85 hours of content, and more than 300 speakers.

Registration open: EURETINA 2021 virtual programme provides 4 days, 5 channels

Registration is open now for this year’s EURETINA 2021 virtual programme, scheduled for 9 to 12 September.

Early fees are available until Tuesday 31 August. Delegates may register for the virtual congress until 12:30 pm Central European Summer Time (CEST) on Sunday 12 September.

Prof Frank Holz

Prof. Holz

“This year marks the society’s 21st annual congress and our second in virtual format,” said Prof Frank G. Holz, EURETINA President. “Thanks to the hard work of the board and programme committee, we anticipate a dynamic meeting, which, this year, will extend to 4 days of content across 5 parallel channels.”

Programming includes 16 EURETINA sessions; 22 symposia; 44 instructional courses; 85 hours of content, and more than 300 speakers.

Featured lectures include:

  • Thursday 9 September: EURETINA Lecture 2021: “Choriocapillaris in AMD: New insights into pathophysiology” by SriniVas Sadda, MD, Los Angeles, California, USA
  • Saturday 11 September: Gisbert Richard Lecture 2021: “Visual acuity following retinal detachment surgery” by Prof. Heinrich Heimann, MD, Liverpool, UK
  • Saturday 11 September: Kreissig Award Lecture: “Neuroprotective strategy for non-arteritic central retinal artery occlusion” by Ogugua Okonkwo, MD, FRCS (Edin), FASRS, Nigeria
  • Saturday 11 September: Ophthalmologica Award Lecture: “Serous business: Dissecting the broad spectrum of diseases with subretinal fluid in the macula” by Prof. dr. Camiel Boon, MD, The Netherlands
Recent Videos
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
© 2024 MJH Life Sciences

All rights reserved.